Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-014525
Filing Date
2025-05-23
Accepted
2025-05-23 17:45:05
Documents
1
Period of Report
2025-05-22

Document Format Files

Seq Description Document Type Size
1 form4-05232025_050501.html 4  
1 form4-05232025_050501.xml 4 4210
  Complete submission text file 0001415889-25-014525.txt   5645
Mailing Address 535 BOYLSTON ST., 2ND FLOOR BOSTON MA 02116
Business Address
Namouni Fouad (Reporting) CIK: 0001815851 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39979 | Film No.: 25983627

Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Issuer) CIK: 0001817229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)